nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Tachycardia—Etoposide—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Nabilone—Dyspnoea—Cisplatin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Nabilone—Hyperhidrosis—Etoposide—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Nabilone—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Nabilone—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Nabilone—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Nabilone—Anorexia—Etoposide—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Nabilone—Diarrhoea—Thiotepa—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Nabilone—Decreased appetite—Cisplatin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Nabilone—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Nabilone—Drowsiness—Methotrexate—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Nabilone—Depression—Methotrexate—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Nabilone—Hypotension—Etoposide—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Nabilone—Gastritis—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Nabilone—Pain—Cisplatin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Nabilone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Nabilone—Dizziness—Thiotepa—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Nabilone—Stomatitis—Methotrexate—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Nabilone—Pollakiuria—Epirubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Nabilone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Nabilone—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Nabilone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Nabilone—Paraesthesia—Etoposide—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Nabilone—Dyspnoea—Etoposide—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Nabilone—Somnolence—Etoposide—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Nabilone—Epistaxis—Methotrexate—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Nabilone—Vomiting—Thiotepa—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Nabilone—Drowsiness—Epirubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Nabilone—Rash—Thiotepa—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Nabilone—Dermatitis—Thiotepa—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Nabilone—Headache—Thiotepa—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Nabilone—Decreased appetite—Etoposide—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Nabilone—Body temperature increased—Cisplatin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Nabilone—Fatigue—Etoposide—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Nabilone—Stomatitis—Epirubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Nabilone—Pain—Etoposide—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Nabilone—Constipation—Etoposide—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Nabilone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Nabilone—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Nabilone—Asthenia—Gemcitabine—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Nabilone—Pharyngitis—Methotrexate—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Nabilone—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Nabilone—Epistaxis—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Nabilone—Pruritus—Gemcitabine—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Nabilone—Nausea—Thiotepa—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Nabilone—Feeling abnormal—Etoposide—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Nabilone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Nabilone—Pruritus—Fluorouracil—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Nabilone—Drowsiness—Doxorubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Nabilone—Visual impairment—Methotrexate—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Nabilone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Nabilone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Nabilone—Stomatitis—Doxorubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Nabilone—Abdominal pain—Etoposide—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Nabilone—Body temperature increased—Etoposide—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Nabilone—Eye disorder—Methotrexate—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Nabilone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Nabilone—Tinnitus—Methotrexate—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Nabilone—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Nabilone—Asthenia—Cisplatin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Nabilone—Pharyngitis—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Nabilone—Epistaxis—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Nabilone—Dizziness—Fluorouracil—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Nabilone—Visual impairment—Epirubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Nabilone—Chills—Methotrexate—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Nabilone—Diarrhoea—Cisplatin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Nabilone—Vomiting—Gemcitabine—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Nabilone—Rash—Gemcitabine—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Nabilone—Dermatitis—Gemcitabine—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Nabilone—Eye disorder—Epirubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Nabilone—Hypersensitivity—Etoposide—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Nabilone—Tinnitus—Epirubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Nabilone—Headache—Gemcitabine—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Nabilone—Flushing—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Nabilone—Vomiting—Fluorouracil—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Nabilone—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Nabilone—Rash—Fluorouracil—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Nabilone—Dermatitis—Fluorouracil—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Nabilone—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Nabilone—Headache—Fluorouracil—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Nabilone—Asthenia—Etoposide—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Nabilone—Back pain—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Nabilone—Chills—Epirubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Nabilone—Pruritus—Etoposide—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Nabilone—Arrhythmia—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Nabilone—Visual impairment—Doxorubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Nabilone—Nausea—Gemcitabine—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Nabilone—Vomiting—Cisplatin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Nabilone—Vision blurred—Methotrexate—urinary bladder cancer	0.001	0.001	CcSEcCtD
Nabilone—Rash—Cisplatin—urinary bladder cancer	0.000997	0.000997	CcSEcCtD
Nabilone—Dermatitis—Cisplatin—urinary bladder cancer	0.000996	0.000996	CcSEcCtD
Nabilone—Diarrhoea—Etoposide—urinary bladder cancer	0.000991	0.000991	CcSEcCtD
Nabilone—Nausea—Fluorouracil—urinary bladder cancer	0.000991	0.000991	CcSEcCtD
Nabilone—Eye disorder—Doxorubicin—urinary bladder cancer	0.000988	0.000988	CcSEcCtD
Nabilone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000986	0.000986	CcSEcCtD
Nabilone—Tinnitus—Doxorubicin—urinary bladder cancer	0.000986	0.000986	CcSEcCtD
Nabilone—Anaemia—Methotrexate—urinary bladder cancer	0.000983	0.000983	CcSEcCtD
Nabilone—Flushing—Doxorubicin—urinary bladder cancer	0.000981	0.000981	CcSEcCtD
Nabilone—Tension—Epirubicin—urinary bladder cancer	0.000976	0.000976	CcSEcCtD
Nabilone—Nervousness—Epirubicin—urinary bladder cancer	0.000966	0.000966	CcSEcCtD
Nabilone—Back pain—Epirubicin—urinary bladder cancer	0.000962	0.000962	CcSEcCtD
Nabilone—Malaise—Methotrexate—urinary bladder cancer	0.000959	0.000959	CcSEcCtD
Nabilone—Dizziness—Etoposide—urinary bladder cancer	0.000958	0.000958	CcSEcCtD
Nabilone—Vertigo—Methotrexate—urinary bladder cancer	0.000955	0.000955	CcSEcCtD
Nabilone—Leukopenia—Methotrexate—urinary bladder cancer	0.000952	0.000952	CcSEcCtD
Nabilone—Chills—Doxorubicin—urinary bladder cancer	0.000949	0.000949	CcSEcCtD
Nabilone—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000945	0.000945	CcSEcCtD
Nabilone—Nausea—Cisplatin—urinary bladder cancer	0.000939	0.000939	CcSEcCtD
Nabilone—Vision blurred—Epirubicin—urinary bladder cancer	0.000938	0.000938	CcSEcCtD
Nabilone—Cough—Methotrexate—urinary bladder cancer	0.000928	0.000928	CcSEcCtD
Nabilone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000923	0.000923	CcSEcCtD
Nabilone—Convulsion—Methotrexate—urinary bladder cancer	0.000921	0.000921	CcSEcCtD
Nabilone—Vomiting—Etoposide—urinary bladder cancer	0.000921	0.000921	CcSEcCtD
Nabilone—Anaemia—Epirubicin—urinary bladder cancer	0.00092	0.00092	CcSEcCtD
Nabilone—Agitation—Epirubicin—urinary bladder cancer	0.000914	0.000914	CcSEcCtD
Nabilone—Rash—Etoposide—urinary bladder cancer	0.000913	0.000913	CcSEcCtD
Nabilone—Dermatitis—Etoposide—urinary bladder cancer	0.000913	0.000913	CcSEcCtD
Nabilone—Headache—Etoposide—urinary bladder cancer	0.000907	0.000907	CcSEcCtD
Nabilone—Myalgia—Methotrexate—urinary bladder cancer	0.000905	0.000905	CcSEcCtD
Nabilone—Chest pain—Methotrexate—urinary bladder cancer	0.000905	0.000905	CcSEcCtD
Nabilone—Arthralgia—Methotrexate—urinary bladder cancer	0.000905	0.000905	CcSEcCtD
Nabilone—Tension—Doxorubicin—urinary bladder cancer	0.000903	0.000903	CcSEcCtD
Nabilone—Malaise—Epirubicin—urinary bladder cancer	0.000897	0.000897	CcSEcCtD
Nabilone—Discomfort—Methotrexate—urinary bladder cancer	0.000894	0.000894	CcSEcCtD
Nabilone—Nervousness—Doxorubicin—urinary bladder cancer	0.000894	0.000894	CcSEcCtD
Nabilone—Vertigo—Epirubicin—urinary bladder cancer	0.000894	0.000894	CcSEcCtD
Nabilone—Syncope—Epirubicin—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Nabilone—Leukopenia—Epirubicin—urinary bladder cancer	0.000891	0.000891	CcSEcCtD
Nabilone—Back pain—Doxorubicin—urinary bladder cancer	0.00089	0.00089	CcSEcCtD
Nabilone—Palpitations—Epirubicin—urinary bladder cancer	0.000879	0.000879	CcSEcCtD
Nabilone—Confusional state—Methotrexate—urinary bladder cancer	0.000875	0.000875	CcSEcCtD
Nabilone—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000874	0.000874	CcSEcCtD
Nabilone—Cough—Epirubicin—urinary bladder cancer	0.000868	0.000868	CcSEcCtD
Nabilone—Vision blurred—Doxorubicin—urinary bladder cancer	0.000868	0.000868	CcSEcCtD
Nabilone—Convulsion—Epirubicin—urinary bladder cancer	0.000862	0.000862	CcSEcCtD
Nabilone—Infection—Methotrexate—urinary bladder cancer	0.000862	0.000862	CcSEcCtD
Nabilone—Nausea—Etoposide—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Nabilone—Hypertension—Epirubicin—urinary bladder cancer	0.000859	0.000859	CcSEcCtD
Nabilone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000854	0.000854	CcSEcCtD
Nabilone—Anaemia—Doxorubicin—urinary bladder cancer	0.000851	0.000851	CcSEcCtD
Nabilone—Chest pain—Epirubicin—urinary bladder cancer	0.000847	0.000847	CcSEcCtD
Nabilone—Myalgia—Epirubicin—urinary bladder cancer	0.000847	0.000847	CcSEcCtD
Nabilone—Arthralgia—Epirubicin—urinary bladder cancer	0.000847	0.000847	CcSEcCtD
Nabilone—Agitation—Doxorubicin—urinary bladder cancer	0.000846	0.000846	CcSEcCtD
Nabilone—Anxiety—Epirubicin—urinary bladder cancer	0.000844	0.000844	CcSEcCtD
Nabilone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000839	0.000839	CcSEcCtD
Nabilone—Discomfort—Epirubicin—urinary bladder cancer	0.000837	0.000837	CcSEcCtD
Nabilone—Malaise—Doxorubicin—urinary bladder cancer	0.00083	0.00083	CcSEcCtD
Nabilone—Dry mouth—Epirubicin—urinary bladder cancer	0.000828	0.000828	CcSEcCtD
Nabilone—Vertigo—Doxorubicin—urinary bladder cancer	0.000827	0.000827	CcSEcCtD
Nabilone—Anorexia—Methotrexate—urinary bladder cancer	0.000827	0.000827	CcSEcCtD
Nabilone—Syncope—Doxorubicin—urinary bladder cancer	0.000826	0.000826	CcSEcCtD
Nabilone—Leukopenia—Doxorubicin—urinary bladder cancer	0.000824	0.000824	CcSEcCtD
Nabilone—Confusional state—Epirubicin—urinary bladder cancer	0.000819	0.000819	CcSEcCtD
Nabilone—Palpitations—Doxorubicin—urinary bladder cancer	0.000814	0.000814	CcSEcCtD
Nabilone—Hypotension—Methotrexate—urinary bladder cancer	0.000811	0.000811	CcSEcCtD
Nabilone—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000809	0.000809	CcSEcCtD
Nabilone—Infection—Epirubicin—urinary bladder cancer	0.000807	0.000807	CcSEcCtD
Nabilone—Cough—Doxorubicin—urinary bladder cancer	0.000803	0.000803	CcSEcCtD
Nabilone—Shock—Epirubicin—urinary bladder cancer	0.000799	0.000799	CcSEcCtD
Nabilone—Convulsion—Doxorubicin—urinary bladder cancer	0.000798	0.000798	CcSEcCtD
Nabilone—Hypertension—Doxorubicin—urinary bladder cancer	0.000795	0.000795	CcSEcCtD
Nabilone—Tachycardia—Epirubicin—urinary bladder cancer	0.000792	0.000792	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000791	0.000791	CcSEcCtD
Nabilone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000785	0.000785	CcSEcCtD
Nabilone—Insomnia—Methotrexate—urinary bladder cancer	0.000785	0.000785	CcSEcCtD
Nabilone—Arthralgia—Doxorubicin—urinary bladder cancer	0.000784	0.000784	CcSEcCtD
Nabilone—Chest pain—Doxorubicin—urinary bladder cancer	0.000784	0.000784	CcSEcCtD
Nabilone—Myalgia—Doxorubicin—urinary bladder cancer	0.000784	0.000784	CcSEcCtD
Nabilone—Anxiety—Doxorubicin—urinary bladder cancer	0.000781	0.000781	CcSEcCtD
Nabilone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000779	0.000779	CcSEcCtD
Nabilone—Discomfort—Doxorubicin—urinary bladder cancer	0.000774	0.000774	CcSEcCtD
Nabilone—Anorexia—Epirubicin—urinary bladder cancer	0.000774	0.000774	CcSEcCtD
Nabilone—Dyspnoea—Methotrexate—urinary bladder cancer	0.000774	0.000774	CcSEcCtD
Nabilone—Somnolence—Methotrexate—urinary bladder cancer	0.000771	0.000771	CcSEcCtD
Nabilone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000767	0.000767	CcSEcCtD
Nabilone—Dyspepsia—Methotrexate—urinary bladder cancer	0.000764	0.000764	CcSEcCtD
Nabilone—Hypotension—Epirubicin—urinary bladder cancer	0.000759	0.000759	CcSEcCtD
Nabilone—Confusional state—Doxorubicin—urinary bladder cancer	0.000758	0.000758	CcSEcCtD
Nabilone—Decreased appetite—Methotrexate—urinary bladder cancer	0.000754	0.000754	CcSEcCtD
Nabilone—Fatigue—Methotrexate—urinary bladder cancer	0.000748	0.000748	CcSEcCtD
Nabilone—Infection—Doxorubicin—urinary bladder cancer	0.000746	0.000746	CcSEcCtD
Nabilone—Pain—Methotrexate—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00074	0.00074	CcSEcCtD
Nabilone—Shock—Doxorubicin—urinary bladder cancer	0.000739	0.000739	CcSEcCtD
Nabilone—Insomnia—Epirubicin—urinary bladder cancer	0.000734	0.000734	CcSEcCtD
Nabilone—Tachycardia—Doxorubicin—urinary bladder cancer	0.000733	0.000733	CcSEcCtD
Nabilone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000729	0.000729	CcSEcCtD
Nabilone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000726	0.000726	CcSEcCtD
Nabilone—Dyspnoea—Epirubicin—urinary bladder cancer	0.000724	0.000724	CcSEcCtD
Nabilone—Somnolence—Epirubicin—urinary bladder cancer	0.000722	0.000722	CcSEcCtD
Nabilone—Anorexia—Doxorubicin—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Nabilone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000715	0.000715	CcSEcCtD
Nabilone—Dyspepsia—Epirubicin—urinary bladder cancer	0.000715	0.000715	CcSEcCtD
Nabilone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00071	0.00071	CcSEcCtD
Nabilone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000706	0.000706	CcSEcCtD
Nabilone—Hypotension—Doxorubicin—urinary bladder cancer	0.000702	0.000702	CcSEcCtD
Nabilone—Fatigue—Epirubicin—urinary bladder cancer	0.0007	0.0007	CcSEcCtD
Nabilone—Constipation—Epirubicin—urinary bladder cancer	0.000694	0.000694	CcSEcCtD
Nabilone—Pain—Epirubicin—urinary bladder cancer	0.000694	0.000694	CcSEcCtD
Nabilone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000686	0.000686	CcSEcCtD
Nabilone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000686	0.000686	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000685	0.000685	CcSEcCtD
Nabilone—Insomnia—Doxorubicin—urinary bladder cancer	0.00068	0.00068	CcSEcCtD
Nabilone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000675	0.000675	CcSEcCtD
Nabilone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Nabilone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000669	0.000669	CcSEcCtD
Nabilone—Somnolence—Doxorubicin—urinary bladder cancer	0.000668	0.000668	CcSEcCtD
Nabilone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000664	0.000664	CcSEcCtD
Nabilone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000661	0.000661	CcSEcCtD
Nabilone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000653	0.000653	CcSEcCtD
Nabilone—Fatigue—Doxorubicin—urinary bladder cancer	0.000648	0.000648	CcSEcCtD
Nabilone—Constipation—Doxorubicin—urinary bladder cancer	0.000642	0.000642	CcSEcCtD
Nabilone—Pain—Doxorubicin—urinary bladder cancer	0.000642	0.000642	CcSEcCtD
Nabilone—Body temperature increased—Epirubicin—urinary bladder cancer	0.000642	0.000642	CcSEcCtD
Nabilone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000642	0.000642	CcSEcCtD
Nabilone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000639	0.000639	CcSEcCtD
Nabilone—Asthenia—Methotrexate—urinary bladder cancer	0.000623	0.000623	CcSEcCtD
Nabilone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000619	0.000619	CcSEcCtD
Nabilone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000614	0.000614	CcSEcCtD
Nabilone—Pruritus—Methotrexate—urinary bladder cancer	0.000614	0.000614	CcSEcCtD
Nabilone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000598	0.000598	CcSEcCtD
Nabilone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000594	0.000594	CcSEcCtD
Nabilone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000594	0.000594	CcSEcCtD
Nabilone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000594	0.000594	CcSEcCtD
Nabilone—Asthenia—Epirubicin—urinary bladder cancer	0.000583	0.000583	CcSEcCtD
Nabilone—Pruritus—Epirubicin—urinary bladder cancer	0.000574	0.000574	CcSEcCtD
Nabilone—Dizziness—Methotrexate—urinary bladder cancer	0.000574	0.000574	CcSEcCtD
Nabilone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000556	0.000556	CcSEcCtD
Nabilone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000554	0.000554	CcSEcCtD
Nabilone—Vomiting—Methotrexate—urinary bladder cancer	0.000552	0.000552	CcSEcCtD
Nabilone—Rash—Methotrexate—urinary bladder cancer	0.000547	0.000547	CcSEcCtD
Nabilone—Dermatitis—Methotrexate—urinary bladder cancer	0.000547	0.000547	CcSEcCtD
Nabilone—Headache—Methotrexate—urinary bladder cancer	0.000544	0.000544	CcSEcCtD
Nabilone—Asthenia—Doxorubicin—urinary bladder cancer	0.000539	0.000539	CcSEcCtD
Nabilone—Dizziness—Epirubicin—urinary bladder cancer	0.000537	0.000537	CcSEcCtD
Nabilone—Pruritus—Doxorubicin—urinary bladder cancer	0.000532	0.000532	CcSEcCtD
Nabilone—Vomiting—Epirubicin—urinary bladder cancer	0.000516	0.000516	CcSEcCtD
Nabilone—Nausea—Methotrexate—urinary bladder cancer	0.000515	0.000515	CcSEcCtD
Nabilone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000514	0.000514	CcSEcCtD
Nabilone—Rash—Epirubicin—urinary bladder cancer	0.000512	0.000512	CcSEcCtD
Nabilone—Dermatitis—Epirubicin—urinary bladder cancer	0.000512	0.000512	CcSEcCtD
Nabilone—Headache—Epirubicin—urinary bladder cancer	0.000509	0.000509	CcSEcCtD
Nabilone—Dizziness—Doxorubicin—urinary bladder cancer	0.000497	0.000497	CcSEcCtD
Nabilone—Nausea—Epirubicin—urinary bladder cancer	0.000482	0.000482	CcSEcCtD
Nabilone—Vomiting—Doxorubicin—urinary bladder cancer	0.000478	0.000478	CcSEcCtD
Nabilone—Rash—Doxorubicin—urinary bladder cancer	0.000474	0.000474	CcSEcCtD
Nabilone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000473	0.000473	CcSEcCtD
Nabilone—Headache—Doxorubicin—urinary bladder cancer	0.000471	0.000471	CcSEcCtD
Nabilone—Nausea—Doxorubicin—urinary bladder cancer	0.000446	0.000446	CcSEcCtD
